Docosixine

N/A

Report date: 2025/03/19 20:00:56

NME

Base Information

Drug NameDocosixine

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase inhibitors

TargetsMatrix metalloproteinase

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCliniGenetics SA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCliniGenetics SA

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

ATC CodeN/A